Journal of Medicinal Chemistry · 2009 · 64 citations · 13 references
MedicineMedicinal ChemistryOncologyCancer PharmacologyDrug DesignMolecular OncologyAnticancer Prodrug DesignApoptosis PharmacologyCytotoxic ChemotherapyTopoisomerase InhibitorsAkt Survival SignalingAntiproliferative AgentsAntiproliferative Drug ActionDna Damage Response Inhibitors
Naphthalimmide (NI) and 1,4,5,8-naphthalentetracarboxylic diimide (NDI) derivatives were synthesized and evaluated for their antiproliferative activity. NDI derivatives 1-9 were more cytotoxic than the corresponding NI derivatives 10-18. The molecular mechanisms of 1 and 2 were investigated in comparison to mitonafide. They interacted with DNA, were not topoisomerase IIalpha poisons, triggered caspase activation, caused p53 protein accumulation, and down-regulated AKT survival. Furthermore, 1 and 2 caused a decrease of ERK1/2 and, unlike mitonafide, inhibited ERKs phosphorylation.
13
Bert Vogelstein, David P. Lane, Arnold J. Levine · Nature · 2000 · 6.6K citations
Eric Van Quaquebeke, Tine Mahieu, Patrick Dumont et al. · Journal of Medicinal Chemistry · 2007 · 126 citations